Background Hypoglycemia (low blood sugar) often occurs as an adverse effect of antidiabetic drugs. It manifests as activation of the sympathetic nervous system with sweating, palpitations, nausea, tremors, and even unconsciousness and coma. At the first signs of hypoglycemia, the patient should immediately consume 24 to 36 g of glucose (corresponding to 2-3 bread units; … Liquid Dextrose
Products Glucagon is commercially available as an injectable (GlucaGen). It has been approved in many countries since 1965. It is available to patients as a powder and solvent for preparing a solution for injection in a prefilled syringe. The drug is stored in a cool place in the pharmacy until dispensed. Patients can store it … Glucagon (Syringe)
Products Glucagon nasal applicator was approved in the US and EU in 2019 and in many countries in 2020 (Baqsimi, single dose). Glucagon is present in the drug product as a powder for nasal administration. The applicator is stored at room temperature not above 30°C. Structure and properties Glucagon (C153H225N43O49S, Mr = 3483 g/mol) is … Glucagon Nasal Spray
Products Diazoxide is commercially available in capsule form (Proglicem). It has been approved in many countries since 1978. Structure and properties Diazoxide (C8H7ClN2O2S, Mr = 230.7 g/mol) exists as a white powder that is practically insoluble in water. It is a benzothiadiazine derivative and structurally related to the thiazides, but is not diuretic. Effects Diazoxide … Diazoxide
